167 related articles for article (PubMed ID: 6728992)
1. Treatment of depression by altering monoamine metabolism: precursors and metabolic inhibitors.
Baldessarini RJ
Psychopharmacol Bull; 1984; 20(2):224-39. PubMed ID: 6728992
[No Abstract] [Full Text] [Related]
2. [Indoleamine precursors in depression (author's transl)].
Coppen A; Wood K
Encephale; 1979; 5(5 Suppl):627-32. PubMed ID: 95009
[TBL] [Abstract][Full Text] [Related]
3. Defects in monoamine metabolism and their possible importance in the pathogenesis of depressive syndromes.
Coppen A
Psychiatr Neurol Neurochir; 1969; 72(2):173-80. PubMed ID: 5792057
[No Abstract] [Full Text] [Related]
4. 5-Hydroxytryptamine in depression.
Pare CM; Trenchard A; Turner P
Adv Biochem Psychopharmacol; 1974; 11(0):275-9. PubMed ID: 4846267
[No Abstract] [Full Text] [Related]
5. Neurotransmitter precursors for the treatment of depression.
Gelenberg AJ; Gibson CJ; Wojcik JD
Psychopharmacol Bull; 1982 Jan; 18(1):7-18. PubMed ID: 6124021
[No Abstract] [Full Text] [Related]
6. Biochemistry of depression (a review of the literature).
Aillon GA
Behav Neuropsychiatry; 1971 Dec; 3(9):2-5 passim. PubMed ID: 4339741
[No Abstract] [Full Text] [Related]
7. Stereospecific transport carrier systems for L-tyrosine and L-tryptophan in relation to monoamine synthesis.
Bruinvels J; Moleman P
Essays Neurochem Neuropharmacol; 1981; 5():1-24. PubMed ID: 7014213
[No Abstract] [Full Text] [Related]
8. Manipulation of cerebral monoamines in the treatment of human epilepsy: a pilot study.
Chadwick D; Trimble M; Jenner P; Driver MV; Reynolds EH
Epilepsia; 1978 Feb; 19(1):3-10. PubMed ID: 624266
[TBL] [Abstract][Full Text] [Related]
9. Biochemical aspects of depression.
Coppen AJ
Int Psychiatry Clin; 1969; 6(2):53-81. PubMed ID: 5817856
[No Abstract] [Full Text] [Related]
10. Use of neurotransmitter precursors for treatment of depression.
Meyers S
Altern Med Rev; 2000 Feb; 5(1):64-71. PubMed ID: 10696120
[TBL] [Abstract][Full Text] [Related]
11. Depressed states and indolealkylamines.
Coppen AJ
Adv Pharmacol (1962); 1968; 6(Pt B):283-91. PubMed ID: 5301640
[No Abstract] [Full Text] [Related]
12. Proceedings: Amine precursors in depression: studies combining L-DOPA and L-tryptophan.
Dunner DL
Psychopharmacol Bull; 1974 Oct; 10(4):56-7. PubMed ID: 4473796
[No Abstract] [Full Text] [Related]
13. Biogenic amines and affective disorders. A critical analysis.
Luchins D
Int Pharmacopsychiatry; 1976; 11(3):135-49. PubMed ID: 136425
[TBL] [Abstract][Full Text] [Related]
14. [Recent knowledge on the biochemical effects of antidepressive agents].
Rysánek K
Act Nerv Super (Praha); 1968 Feb; 10(1):85-93. PubMed ID: 4882492
[No Abstract] [Full Text] [Related]
15. Skeletal muscle morphology of depressed patients after medication.
Ross-Stanton J; Meltzer HY
Muscle Nerve; 1979; 2(3):239-40. PubMed ID: 503109
[No Abstract] [Full Text] [Related]
16. Biogenic amines and their impact in psychiatry.
Axelrod J
Semin Psychiatry; 1972 Aug; 4(3):199-210. PubMed ID: 4680221
[No Abstract] [Full Text] [Related]
17. Affective disorder: studies with amine precursors.
Dunner DL; Fieve RR
Am J Psychiatry; 1975 Feb; 132(2):180-3. PubMed ID: 1089363
[TBL] [Abstract][Full Text] [Related]
18. Neurotransmitter precursor therapies in affective disorders.
von Lerber-Good WF
Int J Vitam Nutr Res Suppl; 1986; 29():69-82. PubMed ID: 2871118
[No Abstract] [Full Text] [Related]
19. Catecholamines and depression: a physiological theory of depression.
Kicey CA
Am J Nurs; 1974 Nov; 74(11):2018-20. PubMed ID: 4496841
[No Abstract] [Full Text] [Related]
20. The effect of monoamine oxidase inhibitor and amine precursors on epileptic seizures.
Inui M; Azuma H; Nishimura T
Med J Osaka Univ; 1980 Mar; 30(3-4):79-85. PubMed ID: 6774223
[No Abstract] [Full Text] [Related]
[Next] [New Search]
